Navigating Supplement Science: Why Clinical Evidence and Independent Research Matter in Today’s Information Age

In this Pharmacy Times interview, Andrew Shao, PhD, senior vice president for global scientific and regulatory affairs at Niagen Bioscience, discusses how the rapid expansion of accessible health information is shaping consumer behavior in the supplement industry. With research findings, company studies, and even non–peer-reviewed data reaching the public almost instantly, Shao explains that consumers are becoming increasingly savvy and selective—often prioritizing clinically validated products over broad wellness claims. He highlights the importance of independent, peer-reviewed research programs that allow external investigators to design and publish studies without company control, helping build credibility among practitioners and consumers. Shao also notes that pharmacists play a critical role in guiding patients through a crowded supplement marketplace, emphasizing the value of products supported by rigorous clinical trials and third-party certifications from organizations such as NSF and USP.